Answers are grounded in this paper and cite their sources.
Hyperglycemia requiring insulin during induction chemotherapy in pediatric ALL is associated with an increased risk of short-term and long-term complications. Prospective studies are needed to analyze formal screening, preventive measures, and optimal management practices for hyperglycemia during ALL induction chemotherapy.
No takes yet. Share an insight, caveat, or question.
McCormick et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: